Diabetes and CYP2C19 Polymorphism Synergistically Impair the Antiplatelet Activity of Clopidogrel Compared With Ticagrelor in Percutaneous Coronary Intervention–treated Acute Coronary Syndrome Patients
2020 ◽
Vol 76
(4)
◽
pp. 478-488
2020 ◽
2018 ◽
Vol 131
(17)
◽
pp. 2017-2024
◽
2017 ◽
Vol 69
(11)
◽
pp. 1019
◽